Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
58m
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma
Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma have been highlighted in this Industry Outlook article.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
DOJ reaches settlement
DA urges resentencing
Workers reject new contract
Kristy now Category 5
4 astronauts return to Earth
Grammy-winning singer dies
Funeral home owners guilty
AI firm sued over suicide
USF basketball coach dies
US mortgage rate climbs
Hack impacted 100M people
Seeks Jan. 6 case dismissal
New UN climate report
Judge blocks $8.5B deal
MO AG to probe Google
Exonerated after 22 years
Air travel competition probe
US new home sales rise
Arbery case retrial motions
Watchdog cautions firms
LA Times editor quits
Sri Lanka attack alert
Philly synagogue targeted
Sued over E. coli outbreak
Nigeria releases US exec
Mailbox fire damages ballots
NY gun control law ruling
Florida sues Garland
Ohio abortion ban blocked
Related topics
United States
NASDAQ
HIV
Food and Drug Administration
Trodelvy
Feedback